Dong-Hoe Koo

11PUBLICATIONS
52CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 17, 2025
Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.

Tae-Han Kim, Ichiro Uyama, Sun Young Rha

|Oct 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study.

Choong-Kun Lee, Hyo Song Kim, Minkyu Jung

|Jun 26, 2023
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.

Chang Gon Kim, Minkyu Jung, Hyo Song Kim

|Apr 21, 2023
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study.

Dong-Hoe Koo, Keun Seok Lee, Sung Hoon Sim

|Jan 06, 2023
Predicting tolerability of high-dose fentanyl buccal tablets in cancer patients.

Mi-Young Kwon, Mi-Yeon Lee, Yun Jae Han

Pageof 2